Handelsbanken Fonder’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $270M | Sell |
538,524
-96,304
| -15% | -$46.2M | 0.77% | 19 |
|
|
2026
Q1 | $312M | Sell |
634,828
-80,700
| -11% | -$43.8M | 1.04% | 13 |
|
|
2025
Q4 | $415M | Buy |
715,528
+12,390
| +2% | +$7.01M | 1.25% | 11 |
|
|
2025
Q3 | $341M | Buy |
703,138
+202,017
| +40% | +$94M | 1.08% | 13 |
|
|
2025
Q2 | $203M | Buy |
501,121
+107,590
| +27% | +$45M | 0.72% | 19 |
|
|
2025
Q1 | $196M | Buy |
393,531
+19,311
| +5% | +$10.5M | 0.81% | 18 |
|
|
2024
Q4 | $195M | Sell |
374,220
-18,761
| -5% | -$10.3M | 0.74% | 20 |
|
|
2024
Q3 | $243M | Buy |
392,981
+2,320
| +0.6% | +$1.37M | 0.96% | 14 |
|
|
2024
Q2 | $216M | Sell |
390,661
-20,745
| -5% | -$11.9M | 0.94% | 13 |
|
|
2024
Q1 | $239M | Buy |
411,406
+5,831
| +1% | +$3.27M | 1.03% | 13 |
|
|
2023
Q4 | $215M | Buy |
405,575
+51,464
| +15% | +$24.9M | 1.05% | 13 |
|
|
2023
Q3 | $179M | Sell |
354,111
-24,036
| -6% | -$12.8M | 1% | 13 |
|
|
2023
Q2 | $197M | Sell |
378,147
-89,860
| -19% | -$48.5M | 1.06% | 10 |
|
|
2023
Q1 | $270M | Buy |
468,007
+27,615
| +6% | +$15.6M | 1.56% | 7 |
|
|
2022
Q4 | $243M | Sell |
440,392
-704
| -0.2% | -$373K | 1.52% | 6 |
|
|
2022
Q3 | $224M | Buy |
441,096
+16,898
| +4% | +$9.46M | 1.5% | 8 |
|
|
2022
Q2 | $230M | Buy |
424,198
+37,928
| +10% | +$20.9M | 1.5% | 8 |
|
|
2022
Q1 | $228M | Sell |
386,270
-1,699
| -0.4% | -$976K | 1.27% | 11 |
|
|
2021
Q4 | $259M | Buy |
387,969
+16,451
| +4% | +$10.3M | 1.27% | 10 |
|
|
2021
Q3 | $212M | Sell |
371,518
-23,329
| -6% | -$12.8M | 1.11% | 13 |
|
|
2021
Q2 | $199M | Sell |
394,847
-13,768
| -3% | -$6.5M | 1.04% | 14 |
|
|
2021
Q1 | $186M | Buy |
408,615
+10,130
| +3% | +$4.84M | 1.06% | 13 |
|
|
2020
Q4 | $186M | Buy |
398,485
+1,881
| +0.5% | +$882K | 1.13% | 9 |
|
|
2020
Q3 | $175M | Buy |
396,604
+3,362
| +0.9% | +$1.39M | 1.28% | 7 |
|
|
2020
Q2 | $142M | Buy |
393,242
+56,999
| +17% | +$19.1M | 1.19% | 11 |
|
|
2020
Q1 | $95.4M | Sell |
336,243
-18,070
| -5% | -$5.7M | 2.05% | 9 |
|
|
2019
Q4 | $115M | Buy |
354,313
+3,270
| +0.9% | +$992K | 1.99% | 10 |
|
|
2019
Q3 | $102M | Buy |
351,043
+5,325
| +2% | +$1.52M | 2.07% | 8 |
|
|
2019
Q2 | $102M | Sell |
345,718
-15,661
| -4% | -$4.31M | 1.88% | 11 |
|
|
2019
Q1 | $98.9M | Sell |
361,379
-5,975
| -2% | -$1.49M | 1.92% | 8 |
|
|
2018
Q4 | $82.2M | Buy |
367,354
+14,789
| +4% | +$3.47M | 1.66% | 16 |
|
|
2018
Q3 | $86.1M | Buy |
352,565
+45,200
| +15% | +$10.4M | 1.62% | 13 |
|
|
2018
Q2 | $63.7M | Buy |
307,365
+143,800
| +88% | +$30.5M | 1.25% | 18 |
|
|
2018
Q1 | $33.8M | Buy |
163,565
+45,800
| +39% | +$9.61M | 0.66% | 54 |
|
|
2017
Q4 | $22.4M | Buy |
117,765
+300
| +0.3% | +$57.5K | 0.49% | 62 |
|
|
2017
Q3 | $22.2M | Sell |
117,465
-1,000
| -0.8% | -$181K | 0.51% | 59 |
|
|
2017
Q2 | $20.7M | Buy |
118,465
+17,500
| +17% | +$2.94M | 0.53% | 60 |
|
|
2017
Q1 | $15.5M | Buy |
100,965
+5,000
| +5% | +$764K | 0.43% | 74 |
|
|
2016
Q4 | $13.5M | Sell |
95,965
-15,000
| -14% | -$2.21M | 0.41% | 76 |
|
|
2016
Q3 | $17.6M | Sell |
110,965
-1,887
| -2% | -$291K | 0.52% | 74 |
|
|
2016
Q2 | $16.7M | Sell |
112,852
-5,000
| -4% | -$738K | 0.68% | 60 |
|
|
2016
Q1 | $16.7M | Sell |
117,852
-59,887
| -34% | -$8.03M | 0.71% | 57 |
|
|
2015
Q4 | $25.2M | Buy |
+177,739
| New | +$23.7M | 0.49% | 61 |
|
Other funds holding TMO
RG
Handelsbanken Fonder's TMO Position: Q2 2026 in Review
Handelsbanken Fonder reduced its Thermo Fisher Scientific (TMO) stake by 15% in Q2 2026, selling an estimated $46.2M and leaving 538,524 shares worth $270M. The position accounts for 0.77% of the portfolio, ranked #19.
Handelsbanken Fonder first reported a position in TMO in Q4 2015 and has held it in 43 quarters since. The position peaked at $415M in Q4 2025. 1,211 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Handelsbanken Fonder held 538,524 shares of Thermo Fisher Scientific worth $270M as of Q2 2026.
- Handelsbanken Fonder sold 96,304 Thermo Fisher Scientific shares in Q2 2026, an estimated $46.2M.
- Thermo Fisher Scientific made up 0.77% of Handelsbanken Fonder's portfolio in Q2 2026, its #19 holding.
- Handelsbanken Fonder first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 43 quarters since.
- Handelsbanken Fonder's Thermo Fisher Scientific position peaked at $415M in Q4 2025.
- 1,211 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.